CD8A and neoplasm: Later it was shown that CD8+ T cell responses could be raised against malaria antigens [38], and several studies followed that reported α-GalCer-enhanced CD4+ and CD8+ T cell responses to protein and peptide antigens, including tumour antigens [39–41].